View in EDS HTML Full Text PDF Full Text

A phase I, first‐in‐human, randomized dose‐escalation study of anti‐activated factor XII monoclonal antibody garadacimab.

Saved in:
Bibliographic Details
Title: A phase I, first‐in‐human, randomized dose‐escalation study of anti‐activated factor XII monoclonal antibody garadacimab.
Authors: McKenzie, Andrew1 (AUTHOR) Andrew.McKenzie@csl.com.au, Roberts, Anthony1 (AUTHOR), Malandkar, Sourabh1 (AUTHOR), Feuersenger, Henrike2 (AUTHOR), Panousis, Con1 (AUTHOR), Pawaskar, Dipti3 (AUTHOR)
Source: CTS: Clinical & Translational Science. Mar2022, Vol. 15 Issue 3, p626-637. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17528054
DOI:10.1111/cts.13180